Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangling Benda Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Jiangling County, Hubei Province, specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs). Established in 2001, the company is a subsidiary of Benda Pharmaceutical, Inc. and operates a manufacturing facility that has received GMP certification for the production of Ribavirin. Its product portfolio includes Ribavirin, Asarin, Levofloxacin Mesylate, and Ribose, which are used in the treatment of viral infections, bacterial diseases, and as pharmaceutical intermediates. The company serves as a key supplier of bulk chemicals and APIs to both domestic and international pharmaceutical manufacturers, supporting the production of various finished medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangling Benda Pharmaceutical.